Nalaganje...
Niraparib in ovarian cancer: results to date and clinical potential
Ovarian cancer is the first cause of death from gynaecological malignancy. Germline mutation in BRCA1 and 2, two genes involved in the mechanisms of reparation of DNA damage, are showed to be related with the incidence of breast and ovarian cancer, both sporadic and familiar. PARP is a family of enz...
Shranjeno v:
| izdano v: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564880/ https://ncbi.nlm.nih.gov/pubmed/29081841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017718775 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|